Upgrade to SI Premium - Free Trial

Cytokinetics (CYTK) PT Raised to $105 at Jefferies

May 7, 2026 9:46 AM
Jefferies analyst Akash Tewari raised the price target on Cytokinetics (NASDAQ: CYTK) to $105.00 (from $90.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change